The latest news and comment on the National Institute for Health and Care Excellence (Nice)
June 2026
Life-prolonging drug for advanced ovarian cancer gets go-ahead in England
Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years
May 2026
Campaigners threaten legal action over UK-US deal on prices NHS pays for drugs
NHS drugs go-ahead offers lifeline to children with rare muscle-wasting disease
April 2026
Dozens of MPs oppose Streeting’s new power to say what NHS pays for drugs
NHS England to offer weight-loss drugs to 1.2m people to reduce risk of heart attacks and strokes
March 2026
Drug that prevents hot flushes to be available on NHS in England
Veoza, also known as fezolinetant, will be offered to women for whom HRT is unsuitable
January 2026
The ADHD grey zone: why patients are stuck between private diagnosis and NHS care
NHS England pays for private assessments under ‘right to choose’, but can reject diagnoses and is struggling to cope with demand
December 2025
Nils Pratley on finance
The UK’s pharma deal was vital – but the GSK boss is right about US dominance
Nils Pratley
It would be absurd to claim the UK has suddenly become a life-sciences leader thanks to the new pricing and tariffs pact
November 2025
NHS won’t get cutting-edge drugs unless it pays more, says AstraZeneca boss
Pascal Soriot calls for cost-effectiveness thresholds to undergo ‘substantial adjustment based on inflation’
October 2025
Experts consider ‘targeted’ prostate cancer screening to reduce UK deaths
New study found screening can reduce deaths by 13% but that overdiagnosis and subsequent overtreatment remain concerns
Prostate cancer drug that can halve death risk to be offered to thousands in England
At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects
Failed by the NHS on chronic fatigue illness
Letters: Prof Paul Garner, Dr Maria PedersenandDr Alastair Miller, plus two other readers, respond to Patrick Barkham’s article on his daughter’s Lyme disease diagnosis
September 2025
NHS drug pricing is all about the art of the deal
Who benefits if NHS drug prices soar? Donald Trump and big pharma. Just one more way he’s menacing Britain
Polly Toynbee
June 2025
Domestic abuse is ‘public health emergency’, experts say after critical NHS report
Blood cancer patients in England first in world to be offered ‘Trojan horse’ drug
May 2025
BMI of 1 million minority ethnic adults in England wrongly classified
Daily endometriosis pill approved for NHS could help 1,000 women a year
April 2025
Drug that cuts risk of breast cancer returning is approved for use in England
Up to 4,000 patients a year with early stage of disease could receive ribociclib, but charities want wider access to drug
March 2025
‘First-of-a-kind’ daily pill for endometriosis treatment approved for NHS in England
Relugolix-estradiol-norethisterone can be taken at home, eliminating need for trips to clinics for injections
About 336 results for National Institute for Health and Care Excellence
